Progestin-only injectable contraception with depot medroxyprogesterone acetate (DMPA) has the potential to offer top-tier efficacy because it has a first-year failure rate of only 0.3% if used ...
Discover Magazine on MSN8mon
Injectable Contraceptives May Increase the Risk of Developing Brain TumorsStudy participants who had used medroxyprogesterone acetate - an injectable contraceptive commonly known as Depo-Provera - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback